The formation of ice crystals can physically damage the delicate protein structure of a peptide, a process called denaturation
All peptide medications referenced on this page require a clinical evaluation and prescription from a licensed provider
Semaglutide As the OG of GLP-1 agonists, semaglutide's Ozempic iteration took the world by storm in the early 2020s, leading to phrases like the "Ozempic Era." FDA-approved for type 2 diabetes Also approved to reduce the risk of heart attack, stroke, and cardiovascular death in adults with type 2 diabetes and heart disease Approved in 2024 to help protect against kidney disease progression in people with type 2 diabetes and chronic kidney disease FDA-approved for chronic weight management in adults and teens 12+ Also approved to reduce the risk of heart attack, stroke, and cardiovascular death in adults with obesity and heart disease, even without diabetes Oral version of semaglutide Approved for type 2 diabetes Tirzepatide Tirzepatide first entered the public spotlight in May 2022 when the U.S
The Danish drugmaker plans to launch Extensior, a lower-cost authorised version of Ozempic, in South Africa on 27 July through a partnership with Swiss healthcare company Acino
Our providers are US-licensed physicians and nurse practioners and prescriptions are carefully reviewed before being approved
